Advances in 3D bioprinting for cancer biology and precision medicine: From matrix design to application

MS Jung, S Ghamrawi, EY Du… - Advanced …, 2022 - Wiley Online Library
The tumor microenvironment is highly complex owing to its heterogeneous composition and
dynamic nature. This makes tumors difficult to replicate using traditional 2D cell culture …

Bioprinting the cancer microenvironment

YS Zhang, M Duchamp, R Oklu… - ACS biomaterials …, 2016 - ACS Publications
Cancer is intrinsically complex, comprising both heterogeneous cellular compositions and
microenvironmental cues. During the various stages of cancer initiation, development, and …

Advances in 3D bioprinting for the biofabrication of tumor models

MG Sánchez-Salazar, MM Álvarez… - Bioprinting, 2021 - Elsevier
Cancer research depends on the challenging task of producing representative and reliable
models of human disease; these have largely been limited to mouse models or human …

3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing

D Nothdurfter, C Ploner, DC Coraça-Huber… - …, 2022 - iopscience.iop.org
Neuroblastoma is an extracranial solid tumor which develops in early childhood and still has
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …

[HTML][HTML] Immersion bioprinting of tumor organoids in multi-well plates for increasing chemotherapy screening throughput

E Maloney, C Clark, H Sivakumar, KM Yoo, J Aleman… - Micromachines, 2020 - mdpi.com
The current drug development pipeline takes approximately fifteen years and $2.6 billion to
get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures …

Three-dimensional bioprinting of in vitro tumor organoid and organ-on-a-chip models

SR Anderson, EJ Stagner, H Sivakumar, A Skardal - MRS bulletin, 2023 - Springer
In the past decade, organoid and organ-on-a-chip cancer models have rapidly gained
attention as alternatives to traditional two-dimensional cell cultures and murine models …

[HTML][HTML] Recapitulating the cancer microenvironment using Bioprinting technology for precision medicine

J Kim, J Jang, DW Cho - Micromachines, 2021 - mdpi.com
The complex and heterogenous nature of cancer contributes to the development of cancer
cell drug resistance. The construction of the cancer microenvironment, including the cell–cell …

3D bioprinting tumor models mimic the tumor microenvironment for drug screening

X Mi, Z Su, X Yue, Y Ren, X Yang, L Qiang… - Biomaterials …, 2023 - pubs.rsc.org
Cancer is a severe threat to human life and health and represents the main cause of death
globally. Drug therapy is one of the primary means of treating cancer; however, most …

3D bioprinting of tumor models for cancer research

Y Kang, P Datta, S Shanmughapriya… - ACS Applied Bio …, 2020 - ACS Publications
The exact mechanistic understanding of cancer metastasis continues to be unknown,
although it is a major cause of death worldwide. Along with the tumor mass, the tumor …

[HTML][HTML] The tumor-on-chip: Recent advances in the development of microfluidic systems to recapitulate the physiology of solid tumors

G Trujillo-de Santiago, BG Flores-Garza… - Materials, 2019 - mdpi.com
The ideal in vitro recreation of the micro-tumor niche—although much needed for a better
understanding of cancer etiology and development of better anticancer therapies—is highly …